as, Inc.'s ("Ventas" or the "Company") and its
subsidiaries' expected future financial position, results of operations,
cash flows, funds from operations, dividends and dividend plans, financing
plans, business strategy, budgets, projected costs, capital expenditures,
competitive positions, acquisitions, investment opportunities, merger
integration, growth opportunities, expected lease income, continued
qualification as a real estate investment trust ("REIT"), plans and
objectives of management for future operations and statements that include
words such as "anticipate," "if," "believe," "plan," "estimate," "expect,"
"intend," "may," "could," "should," "will" and other similar expressions
are forward-looking statements. Such forward-looking statements are
inherently uncertain, and security holders must recognize that actual
results may differ from the Company's expectations. The Company does not
undertake a duty to update such forward-looking statements, which speak
only as of the date on which they are made.
The Company's actual future results and trends may differ materially
depending on a variety of factors discussed in the Company's filings with
the Securities and Exchange Commission. Factors that may affect the
Company's plans or results include without limitation: (a) the ability and
willingness of the Company's operators, tenants, borrowers, managers and
other third parties, as applicable, to meet and/or perform the obligations
under their various contractual arrangements with the Company; (b) the
ability and willingness of Kindred Healthcare, Inc. (together with its
subsidiaries, "Kindred"), Brookdale Living Communities, Inc. (together with
its subsidiaries, "Brookdale") and Alterra Healthcare Corporation (together
with its subsidiaries, "Alterra") to meet and/or perform their obligations
to indemnify, defend and hold the Company harmless from and against various
claims, litigation and liabilities under the Company's respective
contractual arrangement
'/>"/>
SOURCE Ventas, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related medicine news :1.
Ventas Declares Regular Quarterly Dividend of $0.475 Per Share2.
Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee3.
Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call4.
Ventas Appoints Brush SVP - Senior Housing Development and Operations5.
Ventas Declares Regular Quarterly Dividend of $0.475 Per Share6.
Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance7.
Ventas Enters Agreement to Sell Common Stock8.
Ventas Completes Previously Announced Sale of Common Stock9.
Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.6910.
Ventas to Present at the Citi 2008 Global Property CEO Conference11.
Ventas Appoints James D. Shelton and Robert D. Reed to Board